Adaptive Biotechnologies Corp (ADPT) Company Profile & Statistics

Adaptive Biotechnologies Corp
ADPT
(Nasdaq - US)
Closed
5.84
+0.21 (+3.64%)
in:usd•As of: Nov 08, 2024 15:59 UTC -5
Open
5.94
High
6.34
Low
5.60

About Adaptive Biotechnologies Corp

CEO

Chad Robins

Headquarters

1165 eastlake avenue east, suite 200

seattle, wa 98109, united states

Auditor

Ernst & Young LLP

Employees

709

Share Holders

Website

www.adaptivebiotech.com

Industry

biotechnology

Sector

health technology

Company Overview

Adaptive Biotechnologies Corporation is a commercial-stage biotech company. It develops and commercializes immune-driven clinical products to transform the diagnosis and treatment of disease. The company's product pipeline includes immunoSEQ, clonoSEQ and cellular therapy which are in clinical stage. Adaptive Biotechnologies Corporation is based in Seattle, Washington.

Adaptive Biotechnologies Corp Statistics

Valuation Measures

Market Capitalization ²	860.49M
Enterprise Value	800.66M
Enterprise Value/EBITDA (ttm)	-3.87
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	3.51
Price to Sales (ttm)	5.02
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	54.58%
Operating Margin (ttm)	-107.15%
Profit Margin (ttm)	-126.20%
Return on Equity (ttm)	-60.99%
Return on Invested Capital (ttm)	-72.91%
Return on Assets (ttm)	-27.99%

Income Statement

Revenue (ttm)	168.77M
Revenue Per Share (ttm)	1.14
Gross Profit (ttm)	92.44M
EBITDA (ttm)³	-207.13M
Net Income Avi to Common (ttm)	-213.47M
Diluted EPS (ttm)	-1.47

Share Statistics

Beta (5Y Monthly)	1.45
52-Week Change	29.38%
S&P500 52-Week Change	36.80%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	147.47M
Dividend Yield	0.00%
Float ⁴	138.33M
% Held by Insiders	6.20%
% Held by Institutions	99.17%

Balance Sheet

Total Cash (mrq)	291.88M
Total Cash Per Share (mrq)	1.98
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	3.99%
Quick Ratio (mrq)	3.84%
Book Value Per Share (mrq)	1.64

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.38
Free Cash Flow (ytd)	-58.90M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Adaptive Biotechnologies Corp

Trade With A Regulated Broker